Codexis, Inc.

CDXSNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
1.28 USD
↘ 0.03 (2.29%)AT CLOSE (03:59 PM EDT)
1.30
↗ 0.02 (1.56%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.30
↗ 0.02 (1.56%)
🔴Market: CLOSED

Codexis, Inc. (CDXS) is currently trading at $1.28. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Strong Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, CDXS appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 23, 2026.

Open?$1.30
High?$1.32
Low?$1.27
Prev. Close?$1.31
Volume?542.5K
Avg. Volume?870.5K
VWAP?$1.28
Rel. Volume?0.62x
Bid / Ask
Bid?$1.26 × 200
Ask?$1.30 × 11.1K
Spread?$0.04
Midpoint?$1.28
Valuation & Ratios
Market Cap?140.2M
Shares Out?109.5M
Float?105.4M
Float %?96.3%
P/E Ratio?N/A
P/B Ratio?4.25
EPS?-$0.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Themes
Biotech - Drug Development›Clinical-Stage Platforms
Employees
146
Market Cap
140.2M
Industry
INDUSTRIAL ORGANIC CHEMICALS
Website
www.codexis.com
Listed
2010-04-22
Address
200 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063
Phone: 650-421-8100
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
2
Short Sent.?
39
Piotroski F-Score?2/9Weak
Altman Z-Score?-5.98Distress
Confidence?62%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?4.59%Low
Short Interest?4.8M
Days to Cover?5.0
Free Float105.4M
Avg Daily Volume967.6K
Settlement Date2026-09-30
Financial Health
Current Ratio?3.06Strong
Quick Ratio?2.99Strong
Cash Ratio?1.16Strong
Debt/Equity?1.24Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
42
4.25FAIR▾
P/S?
Peers
100
S&P
71
1.80CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.1CHEAP▾
EV/Sales?
Peers
100
S&P
75
1.98CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-93.2%WEAK▾
ROA?
S&P
3
-25.6%WEAK▾
Cash Flow & Enterprise
FCF?$-12180000
Enterprise Value?$153.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist